Your browser doesn't support javascript.
loading
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy.
Thomas, Ajit G; Wozniak, Krystyna M; Tsukamoto, Takashi; Calvin, David; Wu, Ying; Rojas, Camilo; Vornov, James; Slusher, Barbara S.
Affiliation
  • Thomas AG; Guilford Pharmaceuticals Inc., 6611 Tributary Street, Baltimore, Maryland 21224, USA.
Adv Exp Med Biol ; 576: 327-37; discussion 361-3, 2006.
Article in En | MEDLINE | ID: mdl-16802724
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Glutamate Carboxypeptidase II Limits: Animals / Humans Language: En Journal: Adv Exp Med Biol Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Glutamate Carboxypeptidase II Limits: Animals / Humans Language: En Journal: Adv Exp Med Biol Year: 2006 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos